The management of Crohn's disease is rapidly changing. The advent of potent immunomodulatory and biologic therapies has led to more demanding endpoints for clinical trials than only clinical response and remission. Complete withdrawal of corticosteroids, healing of endoscopically visible lesions, an
β¦ LIBER β¦
CDP870 in Crohn's disease: Reconsidering Endpoints
β Scribed by Trevor A. Winter; Willem J. S. de Villiers; Houssam E. Mardini
- Book ID
- 110087370
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 49 KB
- Volume
- 12
- Category
- Article
- ISSN
- 1078-0998
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Endpoints for clinical trials evaluating
β
Geert R. D'Haens; Richard Fedorak; Marc LΓ©mann; Brian G. Feagan; Michael A. Kamm
π
Article
π
2009
π
John Wiley and Sons
π
English
β 91 KB
π 1 views
Intravenous CDP870, a PEGylated Fabβ² fra
β
T. A. Winter; J. Wright; S. Ghosh; J. Jahnsen; A. Innes; P. Round
π
Article
π
2004
π
John Wiley and Sons
π
English
β 140 KB
CDP571, a humanized anti-tumor necrosis
β
Petar Mamula; Stanley A. Cohen; George D. Ferry; Barbara S. Kirschner; Harland S
π
Article
π
2004
π
John Wiley and Sons
π
English
β 151 KB
Surrogate endpoints in Parkinsonβs disea
β
Kevin M. Biglan; Robert G. Holloway
π
Article
π
2003
π
Springer
π
English
β 415 KB
Crohn's disease in childhood
β
I. R. Sanderson; J. A. Walker-Smith
π
Article
π
1985
π
John Wiley and Sons
π
English
β 499 KB
π 3 views
Schiff' first described a series of children with Crohn's disease in New York in 1945. He took care to exclude other diseases of the gastrointestinal tract with which it might clinically have been mistaken; these included infections by enteropathogenic bacteria and infestations with giardia and amoe
Endocarditis in Crohn's disease
β
Charles Berkelhammer; Jelena Andrejic; Asim Mohammed
π
Article
π
2009
π
John Wiley and Sons
π
English
β 93 KB